0001209191-17-022143.txt : 20170321
0001209191-17-022143.hdr.sgml : 20170321
20170321204335
ACCESSION NUMBER: 0001209191-17-022143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170317
FILED AS OF DATE: 20170321
DATE AS OF CHANGE: 20170321
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-321-5554
MAIL ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Molineaux Christopher P.
CENTRAL INDEX KEY: 0001654773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 17705353
MAIL ADDRESS:
STREET 1: C/O ACLARIS THERAPEUTICS, INC.
STREET 2: 101 LINDENWOOD DRIVE, SUITE 400
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-17
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001654773
Molineaux Christopher P.
C/O ACLARIS THERAPEUTICS, INC.
101 LINDENWOOD DRIVE, SUITE 400
MALVERN
PA
19355
1
0
0
0
Common Stock
2017-03-17
4
M
0
6702
0.41
A
6702
D
Common Stock
2017-03-17
4
M
0
592
1.52
A
7294
D
Common Stock
2017-03-17
4
M
0
311
0.72
A
7605
D
Stock option (right to buy)
0.41
2017-03-17
4
M
0
6702
0.00
D
2024-01-28
Common Stock
6702
1993
D
Stock option (right to buy)
1.52
2017-03-17
4
M
0
592
0.00
D
2024-12-07
Common Stock
592
462
D
Stock option (right to buy)
0.72
2017-03-17
4
M
0
311
0.00
D
2024-08-12
Common Stock
311
171
D
25% of the shares underlying this option vested on January 29, 2015 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date.
25% of the shares underlying this option vested on December 8, 2015 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date.
25% of the shares underlying this option vested on August 13, 2015 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date.
/s/ Brian F. Leaf, attorney-in-fact
2017-03-21